XRAY

Dentsply Sirona Inc. Health Care Dental Equipment & Supplies Russell 3000
$9.53Close $1.9BMarket cap $8.42 – $14.6852-week range Nov 5, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 0 of 8 trend conditions
  • Lagging the market RS 10 · weaker than 90% of stocks over 12 months
  • Far from its high 35% below its 52-week high
  • Results soon Nov 5, 2026, in 4 days
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 35%
1wk up 1.1% price change
1mo up 7.6% price change
12-month return down 23% market up 11% · its own down 36%
F-score 5 / 9 Mixed
Altman Z 0.45 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 1.4× price / book
Earnings yield down 11.8% EBIT / enterprise value
Cheaper than 53% of the market · around average
Revenue growth down 3% year on year
EPS growth — latest quarter
Sales growth down 4% latest quarter · -4 pts
ROE down 36% return on equity
Free cash margin up 3% $104.0M FCF
D/E 1.50 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • took on more long-term debt
  • issued more shares
  • gross margin narrowed
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • short-term liquidity improved
  • assets working harder

Trade setup

ATR% 3.6% $0.34 a day · 2×ATR $8.85
RS 10 / 99 vs the universe
Trend 0 / 8 trend template
Relative volume 0.8× vs 50-day average
Up/down volume 0.70 50 sessions
Implied move — no option chain · report Nov 5, 2026
Trend template · 0 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

3 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
  • Gross margin narrowing Gross margin fell from 51.6% to 50.0%. The company is keeping less of each dollar of sales than it did a year ago.
  • Revenue shrinking Revenue fell 3.0% over the year, from $3.8B to $3.7B.
Last reported May 5, 2026

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.7B -3% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $3.3B FY2021 · $4.2B FY2022 · $3.9B FY2023 · $4.0B FY2024 · $3.8B FY2025 · $3.7B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$598.0M
-$1B $0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$73.0M FY2021 · $411.0M FY2022 · -$950.0M FY2023 · -$132.0M FY2024 · -$910.0M FY2025 · -$598.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $104.0M -63% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $562.0M FY2021 · $515.0M FY2022 · $368.0M FY2023 · $228.0M FY2024 · $281.0M FY2025 · $104.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 50%
  • Net -16%
  • Free cash 3%
-25% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 50% · Net -2% · Free cash 17% FY2021 · Gross 55% · Net 10% · Free cash 12% FY2022 · Gross 54% · Net -24% · Free cash 9% FY2023 · Gross 53% · Net -3% · Free cash 6% FY2024 · Gross 52% · Net -24% · Free cash 7% FY2025 · Gross 50% · Net -16% · Free cash 3%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.7B net debt
  • Cash
  • Long-term debt
$0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $438.0M · Long-term debt $2.0B FY2021 · Cash $339.0M · Long-term debt $1.9B FY2022 · Cash $365.0M · Long-term debt $1.8B FY2023 · Cash $334.0M · Long-term debt $1.8B FY2024 · Cash $272.0M · Long-term debt $1.6B FY2025 · Cash $326.0M · Long-term debt $2.0B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 199.60m -8.7% since FY2020
218.70m 198.80m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 218.70m FY2021 · 217.40m FY2022 · 215.20m FY2023 · 207.20m FY2024 · 198.80m FY2025 · 199.60m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $3.3B $4.2B $3.9B $4.0B $3.8B $3.7B
Gross margin 50% 55% 54% 53% 52% 50%
Operating income -$3.0M $608.0M -$937.0M -$85.0M -$879.0M -$422.0M
Net income -$73.0M $411.0M -$950.0M -$132.0M -$910.0M -$598.0M
Net margin -2% 10% -24% -3% -24% -16%
Earnings per share -$0.33 $1.87 -$4.41 -$0.62 -$4.48 -$3.00
Free cash flow $562.0M $515.0M $368.0M $228.0M $281.0M $104.0M
Free cash margin 17% 12% 9% 6% 7% 3%
Cash $438.0M $339.0M $365.0M $334.0M $272.0M $326.0M
Long-term debt $2.0B $1.9B $1.8B $1.8B $1.6B $2.0B
Shareholders' equity $4.9B $5.0B $3.8B $3.3B $1.9B $1.3B
Shares outstanding 218.70m 217.40m 215.20m 207.20m 198.80m 199.60m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 8, 2025 Quarterly ↗ Mar 31, 2025 38d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Jul 31, 2024 Quarterly ↗ Jun 30, 2024 31d
May 2, 2024 Quarterly ↗ Mar 31, 2024 32d
Feb 29, 2024 Annual ↗ Dec 31, 2023 60d
Nov 2, 2023 Quarterly ↗ Sep 30, 2023 33d

Current reports